Bausch Health Companies Inc.: Diarrhea trials

The registry lists 11 Diarrhea studies with Bausch Health Companies Inc. as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 2 4Phase 3 6Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaRecruitingNCT07285785Phase 4
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment StudyCompletedNCT01543178Phase 3Results posted
• Safety and Tolerability of Crofelemer for HIV-Associated DiarrheaCompletedNCT01374490Phase 3Results posted
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With DiarrheaCompletedNCT01177410Phase 2Results posted
• Rifaximin for Prevention of Travellers' DiarrheaCompletedNCT00742469Phase 3Results posted
• Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaCompletedNCT00547898Phase 3Results posted
• A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)CompletedNCT00269399Phase 3Results posted
• Diarrhea Predominant Irritable Bowel Syndrome in FemalesCompletedNCT00461526Phase 2
• Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.CompletedNCT00328380Phase 3
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel SyndromeCompletedNCT00269412Phase 2
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNCT00101725Phase 2